We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

49 hedge funds and large institutions have $141M invested in AVEO Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,723% more call options, than puts

Call options by funds: $1.6M | Put options by funds: $88K

326% more capital invested

Capital invested by funds: $33.2M → $141M (+$108M)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

0% more funds holding

Funds holding: 49 → 49 (0)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

Holders
49
Holders Change
–
Holders Change %
0%
% of All Funds
1.22%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
15
Increased
9
Reduced
10
Closed
14
Calls
$1.6M
Puts
$88K
Net Calls
+$1.52M
Net Calls Change
+$1.51M

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$6.64M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.36M
3
ACA
Avoro Capital Advisors
New York
+$2.12M
4
Millennium Management
Millennium Management
New York
+$1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$915K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$2.52M
2
GTC
Ghost Tree Capital
New York
-$885K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$872K
4
NLVP
New Leaf Venture Partners
New York
-$787K
5
SCM
Sarissa Capital Management
Connecticut
-$598K
Name Holding Trade Value Shares
Change 		Change in
Stake
FRM
26
Fore Research & Management
New York
$111K +$39.4K +5,000 New
Citadel Advisors
27
Citadel Advisors
Florida
$86K +$21.8K +2,774 +253%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$74K – – –
Deutsche Bank
29
Deutsche Bank
Germany
$66K +$23.6K +3,000 New
State Street
30
State Street
Massachusetts
$57K – – –
Morgan Stanley
31
Morgan Stanley
New York
$54K +$18.7K +2,379 +4,758%
CSS
32
Cubist Systematic Strategies
Connecticut
$51K +$18.1K +2,300 New
GC
33
Guggenheim Capital
Illinois
$46K – – –
Wolverine Trading
34
Wolverine Trading
Illinois
$33K +$12.1K +1,532 New
Goldman Sachs
35
Goldman Sachs
New York
$30K +$10.8K +1,373 New
TSS
36
Two Sigma Securities
New York
$29K +$10.4K +1,316 New
EWM
37
Edge Wealth Management
New York
$22K – – –
ECM
38
Elgethun Capital Management
South Dakota
$22K – – –
Bank of America
39
Bank of America
North Carolina
$11K – – –
PCM
40
Prelude Capital Management
New York
$9K +$3.07K +390 New
Creative Planning
41
Creative Planning
Kansas
$2K -$1.57K -200 -67%
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K -$126 -16 -13%
DADC
43
D.A. Davidson & Co
Montana
$2K – – –
Citigroup
44
Citigroup
New York
$2K +$716 +91 New
AG
45
Advisor Group
Arizona
$1K – – –
GRP
46
Global Retirement Partners
California
$1K – – –
LTFS
47
Ladenburg Thalmann Financial Services
Florida
$1K – – –
GAM
48
Gemmer Asset Management
California
$1K +$205 +26 New
GTC
49
Ghost Tree Capital
New York
– -$885K -150,000 Closed
Alyeska Investment Group
50
Alyeska Investment Group
Illinois
– -$872K -147,820 Closed
1
2
3

AVEO Hedge Fund Activity: Q2 2017 in Review

49 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q2 2017, worth a combined $141M — up 326% from $33.2M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AVEO positions and 14 closed out — a net gain of 1 holder — while 9 added to existing stakes and 10 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $6.64M. The largest seller was Armistice Capital, cutting an estimated $2.52M.

  • 49 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $141M of AVEO Pharmaceuticals, Inc. stock for Q2 2017, up 326% quarter-over-quarter.
  • 15 funds opened new AVEO Pharmaceuticals, Inc. positions in Q2 2017 and 14 closed out, a net change of +1 holder.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q2 2017 was RA Capital Management, an estimated $6.64M added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q2 2017 was Armistice Capital, an estimated $2.52M sold.

Based on aggregated 13F filings for Q2 2017.